NovoCure Shares Fall After Narrower Q3 Loss, Revenue Beat

10:22 AM EDT, 10/29/2026 (MT Newswires) -- NovoCure (NVCR) shares fell 9.6% in early Thursday trading after the company reported a narrower Q3 loss and revenue that beat expectations. The company reported a Q3 net loss Thursday of $0.09 per diluted share, narrowing from a loss of $0.33 a year earlier. Analysts polled by FactSet expected a loss of $0.23. Revenue for the quarter ended Sept. 30 was $193.4 million, up from $167.2 million a year earlier. Analysts expected $182.3 million. The company raised its 2026 revenue guidance to $736 million to $743 million from the prior guidance of $710 million to $725 million. Analysts expect $726.1 million. Price: 12.81, Change: -1.36, Percent Change: -9.60